Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics And Pharmacodynamics of SIF001 in Healthy Subjects and in Epilepsy Patients
Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics And Pharmacodynamics of SIF001 in Healthy Subjects and in Epilepsy Patients
Recruiting · NCT07051629 · Registry updated 2026-06-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics And Pharmacodynamics of SIF001 in Healthy Subjects and in Epilepsy Patients | brain disorder, central nervous system disorder, epilepsy, nervous system disorder | Recruiting | Phase 1 | 2026-06-15 | NCT07051629 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Suninflam Inc | 1 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Center for Neurosciences | Tucson | United States | 19 |
| D&H Tamarac Research Center, LLC | Tamarac | United States | 4 |
| Dent Neurologic Institute | Amherst | United States | 18 |
| Encore Medical Research of Weston, LLC | Weston | United States | 4 |
| Hawaii Pacific Neuroscience, Comprehensive Epilepsy Center | Honolulu | United States | 2 |
| Horizon Clinical Research Center | Cypress | United States | 1 |
| Mid-Atlantic Epilepsy and Sleep Center | Bathesda | United States | 1 |
| OnSite Clinical Solutions, LLC | Charlotte | United States | 3 |
| Quest Research Institute | Farmington Hills | United States | 47 |